The Department of Health have advised the Take Home Naloxone (THN) Pilot has been updated to include an additional brand of Naloxone: Junalox (naloxone hydrochloride 400 microgram/mL injection, 5×1 mL ampoules).
Approved Providers and Authorised Alternative Suppliers may provide Junalox under the THN pilot from 27 August 2020 and lodge claims / data containing Junalox from mid-September once the required changes are made in the Portal.
A notification email will be sent to all Approved Providers and Authorised Alternative Suppliers registered for the THN pilot advising when claims / data can be lodged for the new product.
Please Note: claims and data should not be submitted for Junalox supplied prior to 27 August 2020. Claims submitted by an Approved Provider containing Junalox products with a date of supply prior to 27 August 2020 will receive a payment of $0 for the Junalox component of the claim.
As per existing guidelines, Authorised Alternative Suppliers do not receive payment for handing out naloxone products under the THN Pilot.